Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV001194929 | SCV002022346 | pathogenic | Fanconi anemia complementation group D2 | 2019-07-29 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001194929 | SCV004196740 | pathogenic | Fanconi anemia complementation group D2 | 2023-08-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003523080 | SCV004323833 | pathogenic | Fanconi anemia | 2024-01-06 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asn1151Lysfs*46) in the FANCD2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCD2 are known to be pathogenic (PMID: 17436244). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Fanconi anaemia (PMID: 17436244). ClinVar contains an entry for this variant (Variation ID: 929666). For these reasons, this variant has been classified as Pathogenic. |
Leiden Open Variation Database | RCV001194929 | SCV001364794 | pathogenic | Fanconi anemia complementation group D2 | 2020-02-28 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitter to LOVD: Arleen D. Auerbach. |